Gates, Mary R.
Genentech
2 papers on CoChatORCID 0009-0006-8576-2769
Most cited papers
- Verified
Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors
Shapiro, G. I., LoRusso, P., Kwak, E., Pandya, S., Rudin, C. M., Kurkjian, C., Cleary, J. M., Pilat, M. J., Jones, S., de Crespigny, A., et al. (2020) · Investigational New Drugs
PI3K/AKT/mTOR signaling in cancerMelanoma and MAPK Pathways
Cited by 90
- Verified
Biarylpropylsulfonamides as Novel, Potent Potentiators of 2-Amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic Acid (AMPA) Receptors
Ornstein, P. L., Zimmerman, D. M., Arnold, M. B., Bleisch, T. J., Cantrell, B., Simon, R., Zarrinmayeh, H., Baker, S. R., Gates, M., Tizzano, J. P., et al. (2000) · Journal of Medicinal Chemistry
Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling
Cited by 77
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free